about
Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine.Structural biology and function of solute transporters: implications for identifying and designing substrates.Colesevelam: potential uses for the newest bile resin.Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On StRole of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.Dietary fiber for reducing blood cholesterol.Inhibition of cholesterol absorption: targeting the intestine.The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study.Arylsulfonylamino-benzanilides as inhibitors of the apical sodium-dependent bile salt transporter (SLC10A2).New approaches to atherosclerosis: an overview.Absorption and excretion of colestilan in healthy subjects.Colestipol-induced hepatotoxicity.Treatment of hypercholesterolemia in children and adolescents.Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.Cyclodextrins improve oral absorption of a novel factor Xa inhibitor by interfering with interaction between the drug and bile acids in rats.New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.Effects of cholestyramine and parenteral nutrition on hepatic metabolism of lidocaine: a study using isolated rat liver perfusion.
P2860
Q34033136-77F2FF6D-532A-481F-9E9B-9F1933BFDDDCQ35027925-6A26D067-8191-40EC-968F-C0C1789E568AQ36114340-C3702877-8F3E-4CD5-A829-C0971A817DEAQ36940565-DB7DD523-05AC-4F95-AC94-C18D028ECBCCQ37561301-D1177E9B-84DB-4B6D-ABC2-0B930A73A6E5Q37892891-05A8A1C3-7170-4C87-8EAD-849301F5CC63Q38038125-04C2B758-3DCF-42CA-8341-BEFDDD700998Q38335429-79DB621A-EB00-4331-921B-6A6235D95DB7Q39141566-7BEBA3AC-45BE-45EC-9AAB-EBD7019268B9Q40882484-4A911D3D-B092-4FD2-91C2-C298F165391FQ43225931-41035E63-C480-4DE7-876E-FA4A7843017CQ43580207-89CECBA8-2361-4F0B-9172-3A744C6299E1Q44330244-565ED18F-3021-4206-93F3-110552165096Q44480855-A6A08CB4-67C3-43DB-958B-CF29BCD36A7EQ45182744-CE2EC67C-FD20-4D43-BC40-0F25B061AA32Q47279052-8A545BA7-FE24-4D95-B8A7-808EEDAF5A67Q51558596-409ED4A9-EDA4-4B2C-91A9-32C7C919BC04Q51563087-7B8F431F-9E66-4FD3-AC71-F33A90889571
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bile acid sequestrants.
@en
Bile acid sequestrants.
@nl
type
label
Bile acid sequestrants.
@en
Bile acid sequestrants.
@nl
prefLabel
Bile acid sequestrants.
@en
Bile acid sequestrants.
@nl
P2860
P1476
Bile acid sequestrants.
@en
P2093
P2860
P304
P356
10.1002/J.1552-4604.1990.TB03447.X
P577
1990-02-01T00:00:00Z